18F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer

US12054458B2 · kind B2 · utility

Assignees

• Deutsches Krebsforschungszentrum · DE
• RUPRECHT - KARLS - UNIVERSITÄT HEIDELBERG · DE

Inventors

• Jens Cardinale · Wien, AT
• Martin Schaefer · Penzberg, DE
• Klaus Kopka · Dossenheim, DE
• Matthias Eder · Freiburg (Elbe), DE
• Ulrike Bauder-Wuest · Schriesheim, DE
• Michael Eisenhut · Heidelberg, DE
• Martina Benesova · Neckarsteinach, DE
• Uwe Haberkorn · Schwetzingen, DE
• Frederik GIESEL · Heidelberg, DE

Key dates

• Filing date: Mar 17, 2023
• Grant date: Aug 6, 2024
• Expiry date: Mar 17, 2043

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07B2200/05
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers and imaging agents for various disease states of prostate cancer.